Company page

Adicet Bio, Inc.

Adicet Bio, Inc. is a public biotechnology company based in the United States, trading under the ticker ACET. The company focuses on developing innovative therapies for cancer treatment. As of now, Adicet Bio has a market capitalization of approximately $75.9 million.

ACET:NASDAQUpdated August 31, 2026
Adicet Bio, Inc. logo
Ticker
ACET:NASDAQ
Asset type
Stock
Market cap
$84.8M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD